Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Advances in oligonucleotide drug delivery.

Journal article

Roberts TC. et al, (2020), Nat Rev Drug Discov

Uniform sarcolemmal dystrophin expression is required to prevent extracellular microRNA release and improve dystrophic pathology.

Journal article

van Westering TLE. et al, (2020), J Cachexia Sarcopenia Muscle, 11, 578 - 593

Combined treatment with peptide-conjugated phosphorodiamidate morpholino oligomer (PPMO) and AAV-U7 rescues the severe DMD phenotype in mice

Journal article

WOOD MJ. et al, (2020), Molecular Therapy - Methods and Clinical Development

Cell-penetrating peptides

Patent

RAZ R. et al, (2020)

Cell-Penetrating peptides

Patent

RAZ R. et al, (2020)

Development of LNA Gapmer Oligonucleotide-Based Therapy for ALS/FTD Caused by the C9orf72 Repeat Expansion.

Journal article

Sathyaprakash C. et al, (2020), Methods Mol Biol, 2176, 185 - 208

Doublecortin like kinase 1 regulates α-Synuclein levels and toxicity.

Journal article

Vázquez-Vélez GE. et al, (2019), J Neurosci

Wrangling RNA: Antisense oligonucleotides for neurological disorders

Journal article

Talbot K. and Wood MJA., (2019), Science Translational Medicine, 11, eaay2069 - eaay2069

Load More